A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology (ACOG) guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommen...
Updated data from a National Cancer Institute-sponsored clinical trial conducted by the Cancer and Leukemia Group (CALGB) was presented May 5 at the 13th International Myeloma Workshop in Paris, France...
Ethicon Endo-Surgery (EES) will feature its comprehensive portfolio of colorectal solutions and physician-led educational programs, aimed to advance surgical skills in both open and minimally invasive colorectal procedures to promote better patient outcomes, during the American Society of Colon & Rectal Surgeons (ASCRS) Annual Scientific meeting, May 14-18 in Vancouver, Canada...
Latest Clinical Evidence Supports Promising Outlook For Low-Dose Molecular Breast Imaging (MBI)
5/14/2011
The possibility of low-dose Molecular Breast Imaging (MBI) looks promising according to the most recent clinical evidence revealed this past month at the National Institutes of Health (NIH). Dr. Marcela Bohm-Velez and her colleagues from Associates in Pittsburgh, Pa...
Stage 4 Breast Cancer Patient Refused Entry Onto Plane To South Korea
5/13/2011
Crystal Kim, 62, who has Stage 4 breast cancer and wanted to fly back to South Korea to see her family and get medical treatment before she died, was refused entry onto a Korean Air plane, even though she had a doctor's note. Kim wanted to fly from Seattle, USA, to Incheon, South Korea. Kim was not allowed to get on the plane with her daughter last Sunday...
MiRNA Profiling Could Lead To A Blood Test For Lung Cancer
5/13/2011
Researchers have identified characteristic patterns of molecules called microRNA (miRNA) in the blood of people with lung cancer that might reveal both the presence and aggressiveness of the disease, and perhaps who is at risk of developing it. These patterns may be detectable up to two years before the tumor is found by computed tomography (CT) scans...
Vemurafenib New Drug Application Submitted To FDA For Melanoma
5/13/2011
Daiichi Sankyo announced that applications have been submitted for market approval for vemurafenib (PLX4032/RG7204) for the treatment of metastatic melanoma to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Additionally, a pre-marketing application for approval for a companion diagnostic test has been submitted in the U.S...
Breast Cancer, Debate On The Aesthetic Results Of Breast Cancer Local Treatment In Lisbon
5/13/2011
The international seminar "Turning Subjective Into Objective (TSIO): Cosmetic Breast Assessment of Local Treatment" will take place on 13th May starting at 9.15am. The event is organised by the Champalimaud Foundation (FC), the Faculty of Medicine of the University of Porto (FMUP) and the Institute for Systems and Computer Engineering of Porto (INESC Porto)...
Published today in the American Journal of Public Health, a new study reports an increased distrust of the U.S. health care system as a barrier for women from receiving preventive screening measures of breast and cervical cancer...
Trigger For 'Undruggable' Lung Cancer Gene Offers New Treatment Hope
5/12/2011
Cancer Research UK scientists have discovered that an enzyme called C-Raf controls a hugely important gene responsible for the development of lung cancer, according to research published in Cancer Discovery* yesterday (Wednesday). The important gene - K-Ras - is one of the most commonly mutated genes in cancer...